Squamous cell carcinoma of the temporal bone: the impact of local control on survival

被引:0
|
作者
Dubray-Vautrin, Antoine [1 ,2 ,3 ]
Verillaud, Benjamin [1 ,2 ]
Herman, Philippe [1 ,2 ]
Kania, Romain [1 ,2 ,4 ,5 ]
机构
[1] Univ Paris Cite, Lariboisiere Hosp, Assistance Publ Hop Paris, Dept Otorhinolaryngol Head & Neck Surg,Ctr Neurose, F-75010 Paris, France
[2] Platform Biopathol & Innovat Technol Hlth, UMR 1141 Ctr Developing Brain, Paris Biobank BB 0033 00064, Paris, France
[3] Inst Curie, Dept Otorhinolaryngol Head & Neck Surg, Paris, France
[4] Univ Paris Cite, Lariboisiere Hosp, Assistance Publ Hop Paris, Ctr Neurosensorial Head & Neck Dis,Dept Otorhinola, 2 Rue Ambroise Pare, F-75010 Paris, France
[5] Platform Biopathol & Innovat Technol Hlth, UMR 1141 Ctr Dev Brain, Paris Biobank BB 0033 00064, 2 Rue Ambroise Pare, F-00064 Paris, France
关键词
Temporal bone; squamous cell carcinomas; petrectomy; survival; local control; RADICAL SURGERY; TUMORS;
D O I
10.1080/00016489.2024.2311788
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background Squamous cell carcinoma (SCC) of the temporal bone (TB) is a rare pathology originating from the external auditory canal (EAC). Surgery remains the gold standard to achieve local control.Aims/Objectives:The aim of this study was to evaluate overall survival (OS) and disease-free survival (DFS) after surgery of the SCC of EAC. Material and methodsA retrospective chart review in a tertiary referral center included 26 patients: 23 were operated with lateral temporal bone resection (LTBR, n = 10) and extended temporal bone resection (ETBR, n = 13). The outcomes were OS and DFS. Results Adjuvant radiotherapy was performed in 91.3% (n = 21/23). Mean age was 60.8 and sex ratio was 1. Median follow-up was 43 months; The 5-years OS was 90% (+/- 9.5%) and 47.7% (+/- 12.9%) for stage I/II and III/IV respectively (p = .033). DFS was 67.6% (IC 95%, 51.4%-88.9%) without statistical difference between early advanced stage. Incomplete margins (p = .004) and Stage IV(p < .001) were associated with poorer DFS. Free margins significantly correlated with better OS (HR = 9.8, p = .04). Conclusion En bloc surgical resection with free margins, coupled with postoperative radiotherapy, provides optimal local control. For stage IV tumors, where complete margins are achievable, ETBR is recommended to enhance local control.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [31] Impact of radiotherapy duration on overall survival in squamous cell carcinoma of the anus
    Mehta, Shahil
    Ramey, Stephen J.
    Kwon, Deukwoo
    Rich, Benjamin J.
    Ahmed, Awad A.
    Wolfson, Aaron
    Yechieli, Raphael
    Portelance, Lorraine
    Mellon, Eric A.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (02) : 277 - 290
  • [32] Epidemiology and treatment outcomes of cutaneous squamous cell carcinoma extending to the temporal bone
    Schachtel, Michael J. C.
    Gandhi, Mitesh
    Bowman, James J.
    Porceddu, Sandro, V
    Panizza, Benedict J.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (12): : 2727 - 2743
  • [33] Primary definitive radiotherapy with or without chemotherapy for squamous cell carcinoma of the temporal bone
    Kitani, Yosuke
    Kubota, Akira
    Furukawa, Madoka
    Sato, Kaname
    Nakayama, Yuko
    Nonaka, Tetsuo
    Mizoguchi, Nobutaka
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2016, 273 (05) : 1293 - 1298
  • [34] Squamous cell carcinoma of ear and temporal bone: A retrospective study on clinicopathological predictors
    Li, Wei
    Tucker, Bronwyn
    Hu, Zhan-Dong
    Zhang, Yu-Jie
    Guo, Xue-Xi
    Cai, Wen-Juan
    Zhang, Ming-Fang
    Han, Ya-Ting
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (11): : 2870 - 2877
  • [35] Roles of Epithelial-Mesenchymal Transition in Squamous Cell Carcinoma of the Temporal Bone
    Sugimoto, Hisashi
    Ito, Makoto
    Hatano, Miyako
    Kondo, Satoru
    Suzuki, Shioto
    Yoshizaki, Tomokazu
    OTOLOGY & NEUROTOLOGY, 2011, 32 (03) : 483 - 487
  • [36] Cetuximab with radiotherapy as an alternative treatment for advanced squamous cell carcinoma of the temporal bone
    Ebisumoto, Koji
    Okami, Kenji
    Hamada, Masashi
    Maki, Daisuke
    Sakai, Akihiro
    Saito, Kosuke
    Shimizu, Fukuko
    Kaneda, Shoji
    Iida, Masahiro
    AURIS NASUS LARYNX, 2018, 45 (03) : 637 - 639
  • [37] Treatment for oral squamous cell carcinoma: Impact of surgeon volume on survival
    Liu, Timothy
    David, Michael
    Ellis, Owen
    Low, Tsu-Hui
    Palme, Carsten E.
    Clark, Jonathan
    Batstone, Martin
    ORAL ONCOLOGY, 2019, 96 : 60 - 65
  • [38] Temporal bone squamous cell carcinoma: Analyzing prognosis with univariate and multivariate models
    Zanoletti, Elisabetta
    Marioni, Gino
    Stritoni, Paola
    Lionello, Marco
    Giacomelli, Luciano
    Martini, Alessandro
    Mazzoni, Antonio
    LARYNGOSCOPE, 2014, 124 (05) : 1192 - 1198
  • [39] Temporal Bone Resection for Squamous Cell Carcinoma of the Lateral Skull Base: Systematic Review and Meta-analysis
    McCracken, Matthew
    Pai, Kavya
    Cabrera, Claudia, I
    Johnson, Benjamin R.
    Tamaki, Akina
    Gidley, Paul W.
    Manzoor, Nauman F.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2023, 168 (02) : 154 - 164
  • [40] Prognostic Significance of Systemic Inflammatory Response in Cases of Temporal Bone Squamous Cell Carcinoma
    Komune, Noritaka
    Sato, Kuniaki
    Hongo, Takahiro
    Miyazaki, Masaru
    Masuda, Shogo
    Koike, Kensuke
    Uchi, Ryutaro
    Tsuchihashi, Nana Akagi
    Noda, Teppei
    Kogo, Ryunosuke
    Wakasaki, Takahiro
    Yasumatsu, Ryuji
    Nakagawa, Takashi
    LARYNGOSCOPE, 2021, 131 (08) : 1782 - 1789